A NATIONAL, MULTICENTER, SECONDARY DATA USE STUDY EVALUATING EFFICACY AND RETENTION OF FIRST-LINE BIOLOGIC TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-LIFE SETTING FROM TURKBIO REGISTRY

dc.contributor.authorYazici, A
dc.contributor.authorIsik, OO
dc.contributor.authorDalkiliç, E
dc.contributor.authorKoca, SS
dc.contributor.authorPehlivan, Y
dc.contributor.authorSenel, S
dc.contributor.authorInanc, N
dc.contributor.authorAkar, S
dc.contributor.authorYilmaz, S
dc.contributor.authorGündüz, ÖS
dc.contributor.authorCefle, A
dc.contributor.authorOnen, F
dc.date.accessioned2025-04-10T10:37:08Z
dc.date.available2025-04-10T10:37:08Z
dc.identifier.e-issn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttp://hdl.handle.net/20.500.14701/42856
dc.language.isoEnglish
dc.titleA NATIONAL, MULTICENTER, SECONDARY DATA USE STUDY EVALUATING EFFICACY AND RETENTION OF FIRST-LINE BIOLOGIC TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-LIFE SETTING FROM TURKBIO REGISTRY
dc.typeMeeting Abstract

Files